Predictive Oncology News and Activities

Predictive Oncology is a company listed under the stock ticker POAI (US).

Acquisition, funding and merger involving Predictive Oncology.

• Predictive Oncology and Lunai Bioworks have announced they will merge  (posted on January 7 2025)..

View the org chart displaying its 9 main executives

Most searched biographies at Predictive Oncology

• Raymond Vennare, Chief Executive Officer and Chairman of the Board
• Matthew Hawryluk, Director
• Chuck Nuzum, Director

Popular executive movements at Predictive Oncology

• Sara Turken has joined the company as General Counsel  (posted on October 14 2025).
• Thomas Mclaughlin has joined the company as Chief Investment Officer  (posted on October 14 2025).

Create your alert
to follow the executive moves at Predictive Oncology.

Predictive Oncology has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Predictive Oncology

Social media about Predictive Oncology

• Predictive Oncology on Wikipedia, Google News & Yahoo Finance
• Predictive Oncology on LinkedIn, X (Twitter) & YouTube